12:00 AM
Nov 16, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

sNN0029 regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for NeuroNova's sNN0029 to treat amyotrophic lateral...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >